Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

3.8%

2 terminated/withdrawn out of 52 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

6%

3 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

11 recruiting1 with results

Enrollment Performance

Analytics

N/A
24(70.6%)
Phase 2
7(20.6%)
Phase 4
2(5.9%)
Phase 3
1(2.9%)
34Total
N/A(24)
Phase 2(7)
Phase 4(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (52)

Showing 20 of 52 trials
NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT07411573Active Not Recruiting

Multimodal Neurofunctional Profiling in Stroke

Role: collaborator

NCT03012971Not ApplicableCompleted

Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery

Role: collaborator

NCT03012984Not ApplicableCompleted

Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium

Role: collaborator

NCT06416657Not ApplicableRecruiting

General Anesthesia vs Local Anesthesia for Endovascular Treatment in Patients With Unruptured Intracranial Aneurysm Using Flow Diverter

Role: collaborator

NCT06541106Recruiting

Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China

Role: collaborator

NCT07190781Enrolling By Invitation

Development Platform Construction and Application Promotion of Drug-Eluting Stents for Intracranial Aneurysm Interventional Therapy

Role: collaborator

NCT06468436Not ApplicableNot Yet Recruiting

Dexmedetomidine-Esketamine Combination for Sedation and Analgesia in ICU Patients

Role: collaborator

NCT04047576Phase 2Recruiting

Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis

Role: lead

NCT07000617Phase 2Recruiting

A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma

Role: collaborator

NCT06061185Recruiting

Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke

Role: collaborator

NCT06331923Not ApplicableRecruiting

Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes

Role: collaborator

NCT05971810Not ApplicableRecruiting

Perioperative Oral Decontamination and ImmunoNuTrition (POINT) in Elderly

Role: collaborator

NCT06715930Active Not Recruiting

Nomogram for Predicting In-stent Stenosis After Pipeline Embolization Device Treatment in Patients with Intracranial Aneurysm

Role: collaborator

NCT05860270Phase 4Recruiting

Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis

Role: collaborator

NCT06493448Not Yet Recruiting

Prospective Observational Cohort Study

Role: collaborator

NCT04313335Not ApplicableCompleted

Duloxetine for PHN

Role: collaborator

NCT04785976Recruiting

Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage

Role: collaborator

NCT05825391Not ApplicableCompleted

Guided Antiplatelet Therapy in Interventional Treatment of Intracranial Aneurysms

Role: collaborator

NCT05844813Phase 4Enrolling By Invitation

Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma

Role: lead